DEVELOPMENT OF DISINTEGRATION CONTROL MATRIX TABLETS OF FEBUXOSTAT

Authors

  • Kanke Pralhad Dept. of Pharmaceutics Smt. S. S. Patil College of Pharmacy, Yawal Road, Chopda, Maharashtra, India

DOI:

https://doi.org/10.22270/ajprd.v6i4.392

Keywords:

DCMT, Wax, Disintegrating agent, Solid dispersion, Febuxostat.

Abstract

Disintegration control matrix tablet (DCMT) is a new approach for poorly water soluble drugs which successfully sustain the release up to 24hrs by controlling the disintegration rate of tablet. DCMT mainly forms the granules containing drug febuxostat and disintegrant sodium alginate which controls the release of febuxostat by controlling the rate of disintegration in wax coating plays an important role. The sustained release of drug is maintained by increasing the wax coating or decreasing the amount of disintegrant. The release of drug from tablet is uniform throughout till all the drug releases from tablet and it is justified by in-vitro dissolution studies. DCMT increases the solubility of drug and improves the bioavailability without disturbing gastrointestinal transit.

Downloads

Download data is not yet available.

References

Patent: Toshinobo U, Kiyohide H, Fujisava pharmaceutical Co.Ltd. Sustained release tablet EP 0168044 B1.
[2] U. Deokate, J.Wavhale, Disintegration control matrix tablet: A review, Int. J. of Pharm. Res. Scholars, 2015, l-4 (2), 411-416.
[3] Angelo L G, Kenneth G Saag, Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout, Core evidence, 2009, 4, 25 – 36.
[4] Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ibuki R, et al. Development of Novel Sustained-Release System, Disintegration-Controlled Matrix Tablet (Dcmt) With Solid Dispersion Granules Of Nilvadipine (II): In vivo evaluation.,J Control Release,2006,112, 51–56.
[5] ICH Harmonised Tripartite Guideline : Validation of analytical procedures., 2005, 1-13.
[6] Silverstein R.M, Webster F.X, Spectroscopic Identification of Organic Compound,VII edition, John Wiley & Sons,New Jersy, 2005,76-81.
[7] Skoog DA, Holler, F. J. and Timothy, A. N.,Principles of Instrumental Analysis.,V Edi.,Saunders College Publishing. Harcourt Brace College, Publishers.Sweden, 2005, 74-95.
[8] Ministry of Health andWelfare Ministerial Notification No. 104 1994,Japanese Pharmacopoeia, PMDA Publishers, Japan,2011,1–1654.
[9] Dash S, Murthy PN, Nath L, Chowdhury P., Kinetic modeling on drug release from controlled drug delivery systems., Acta Pol Pharm, 2010, 67(3), 217–22.
[10] Kim H, Fassihi R. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J Pharm Sci 1997;86:323
[11] Bhargava. Oral sustained release dosage form: Opportunity to prolong the release of drugs. Int J Adv Res Pharm Biosci 2013;3:7–14.
[12] Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ibuki R, et al. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. J Control Release 2006;112:51–6
[13] Rowe R, Sheskey P OS, editor. Handbook of Pharmaceutical Excipients. Fifth Edit. Pharmaceutical Press; 2006
[14] Arjun S, Ritika S, Faraz J. Sustained Release Drug Delivery System : a Review. Int Res J Pharm 2012;3:21–4
[15] Rathore AS, Jat RC, Sharma N, Tiwari R, Ram S, Of C, et al. AN OVERVIEW : MATRIX TABLET AS CONTROLLED DRUG DELIVERY SYSTEM. Int J Res Dev Pharm Life Sci 2013;2:482–92
[16] Sciences H, Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217–23.

Published

2018-08-23

How to Cite

Pralhad, K. (2018). DEVELOPMENT OF DISINTEGRATION CONTROL MATRIX TABLETS OF FEBUXOSTAT. Asian Journal of Pharmaceutical Research and Development, 6(4), 12–20. https://doi.org/10.22270/ajprd.v6i4.392